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BACKGROUND: The ureteral obstruction (UO) is the most common clinical disorders. This study was designed to investigate the renoprotective effect 
of estradiol in unilateral UO (UUO) and reversible UUO 
(RUUO).  
METHODS: Eighty-four ovareictomized Wistar rats were 
assigned into 14 groups. Group 1 was sham operated group. 
All the groups 2-14 were subject to UUO, however they 
received additional treatments. Group 2-4 received test 
substances (vehicle, 0.1 or 0.05 mg/kg of estradiol) and 
sacrificed after 3 days. Group 5-7 received test substances 
and after 3 days followed by RUUO (obstruction removal) 
and after one day post RUUO were sacrificed. Group 
8-9 followed by RUUO after 3 days and simultaneously 
received estradiol and after one day post RUUO were 
sacrificed. Group 10-12 followed by RUUO after 3 days 
and simultaneously received test substances and after 3 
days post RUUO were sacrificed. Group 13-14 received test 
substances followed by RUUO and received test substances 
again and after 3 days post RUUO were sacrificed.
RESULTS: The estradiol reduced body weight significantly 
(p<0.05) in UUO, and the uterus weight (UW) increased 
significantly by estradiol (p<0.05). The increased serum 
levels of blood urea nitrogen (BUN) and creatinine (Cr), 
and kidney weight (KW) induced by UUO (p<0.05) were 
not attenuated by estradiol. Estradiol treatment did not alter 
the levels  of  BUN,  Cr,  KW,  Cr  clearance  (CrCl), urine 
sodium  excretion  and  urine  flow  when  compared  with 
control.  
CONCLUSION: Although the protective role of estradiol 
in cardiovascular system is well accepted, however our 
findings suggest that its protection during UUO or after 
RUUO in renal system cannot be certain.
KEywORDS: estradiol, ureteral obstruction, renal 
function, rat
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Abstract
Introduction
Ureteral obstruction (UO) is one of the most clinical disorder 
in the progression of renal dysfunction.(1,2) UO reduces the 
glomerular filtration rate (GFR) that leads to natriuresis, 
sodium and water excretion disturbances.(3) In order to 
restore the kidney function after unilateral UO (UUO), the 
obstruction must be removed either by drug or surgery. 
The surgery itself may accompany with alteration of renal 
medullary plasma flow and fluid reabsorption.(4) The UUO 
induced inflammation and tissue damage are resulted from 
stress oxidative formation.(5)
 The antioxidants supplementation is one of best and 
well documented treatment to decrease the stress oxidative. 
In addition, the female sex hormone estrogen has been 
known as an endogenous antioxidant that its protective 
role in cardiovascular system has been accepted in women 
before menopause. The  protective  role  of this hormone 
against  chronic kidney disease also was reported (6), and 
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the protection mechanism may related to glomerulosclerosis 
and interstitial tubular fibrosis prevention (7). Mao, et al., 
performed UUO in rats after 3 weeks of estradiol treatment 
(as prophylaxis), and the GFR and kidney tissue damage 
were evaluated  about two weeks later, and they concluded 
that estradiol affected renal function in UUO model.(8) 
However, the short time effect of estradiol in UUO and after 
UUO removal (reversible UUO, RUUO) need to be studied. 
Based on epidemiological study that estrogen therapy 
improves GFR and blood pressure in postmenopausal 
women (9), there is  hypothesized  that estradiol could 
protect the kidney function against UUO and RUUO. To 
test this hypothesis, renal function makers were assessed in 
UUO and RUUO in ovariectomized estradiol treated rats. 
Methods
This study was performed on 84 ovariectiomized female 
(180±20 g) Wistar rats, and it was approved in advance 
by the Isfahan University of Medical Sciences Ethics 
Committee (No. IR.MUI.REC.1396.2.094 and IR.MUI.
REC.1396.2.096).
Ovariectomy
The animals were anesthetized with chloral hydrate (450 
mg/kg) (Merck, Darmstadt, Germany). The incision was 
Table 1. The summary of study design.
performed in suprapubic region, and the ovaries were 
removed with care. The ovariectomized animals were kept 
in animal cages for one week as a recovery period.
 To collect urine from manipulated kidney, at the 
sacrifice day the right kidney was removed (nephrectomy), 
and after the recovery time, the animals were placed in 
standard metabolic cages for 6 hours to collect the urine 
for the measurements. Finally, the animals were sacrificed 
humanly with anesthetic drug, and the kidney and uterus 
were removed and weighted rapidly.
UUO and RUUO
After recovery period, the rats were anesthetized again, 
and the incision was made on the abdominal skin, the left 
kidneys were pulled out gently and the ureter was isolated 
from other surrounding tissues while the right kidney 
remained intact. The ureter was obstructed with 3-0 nylon 
suture. The kidneys  were  returned  back  to  abdominal 
cavity. In order to perform RUUO model, the animals 
were anesthetized again 3 days after UUO, left kidney and 
obstructed  ureter were exposed and the tie around the ureter 
was released carefully.
Experimental Groups
The experimental groups were assigned as following: 
1) Group 1 (sham operated) was subjected to surgical 
procedure   without   UUO   and   sacrificed   3   days 
Day 1 Day 7 Day 10 Day11 Day 13
1 6 OV
Surgical procedure 
without UUO S NA
NA
2 6 OV UUO + vehicle S NA NA
3 6 OV UUO + Es0.1 S NA NA
4 6 OV UUO + Es0.5 S NA NA
5 6 OV UUO + vehicle RUUO S NA
6 6 OV UUO + Es0.1 RUUO S NA
7 6 OV UUO + Es0.5 RUUO S NA
8 6 OV UUO RUUO + Es0.1 S NA
9 6 OV UUO RUUO + Es0.5 S NA
10 6 OV UUO RUUO + vehicle No intervention S
11 6 OV UUO RUUO + Es0.1 No intervention S
12 6 OV UUO RUUO + Es0.5 No intervention S
13 6 OV UUO + Es0.1 RUUO + Es0.1 No intervention S
14 6 OV UUO + Es0.5 RUUO + Es0.5 No intervention S
Group n
Time
OV: Ovariectomy; UUO: Unilateral ureteral obstruction; ES0.1: 0.1 mg/kg of estradiol treatment; ES0.5: 0.5 
mg/kg of estradiol treatment; RUUO: Unilateral ureteral obstruction removal ; S: Sacrifice; NA: not alive.
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Results
Body weight Changes
The alteration of body weight (BW) during the experiment 
is shown in Figure 1. The upper panel shows the percentage 
(%) change of BW in the animals subjected to UUO treated 
with vehicle or estradiol and compared with sham group. 
later; 2) Group 2-4 were subjected to UUO and received 
vehicle, 0.1 mg/kg of estradiol, or 0.5 mg/kg of estradiol 
respectively, and sacrificed 3 days later; 3) Group 5-7 were 
subjected to UUO and received  vehicle, 0.1 mg/kg of 
estradiol, or 0.5 mg/kg of estradiol respectively, but 3 days 
later, the obstruction was removed (named RUUO), and the 
animals were sacrificed one day post RUUO; 4) Group 8 
and 9 were treated as group 6 and 7 except they received 
estradiol (0.1 or 0.5 mg/kg) after RUUO and sacrificed 
one day post RUUO; 5) Group 10-12 were subjected to 
UUO, and 3 days later the obstruction was removed and 
the animals were treated with vehicle, 0.1 mg/kg estradiol, 
or 0.5 mg/kg of estradiol respectively and sacrificed 3 days 
post RUUO; and 6) Group 13 and 14 were treated as group 
11 and 12 except that they received estradiol both at the day 
of UUO and at the day of RUUO. The summary of groups 
design is shown in Table 1.
Blood Samples and Measurements
Blood samples were taken via heart puncture after urine 
collection and stored in -20oC. The levels of urine and 
serum creatinine (Cr) and blood urea nitrogen (BUN) 
were determined using quantitative diagnostic kits (Pars 
Azmoon,  Tehran, Iran) and automatic analyzer RA-1000 
(Technicon, Dublin, Ireland). Urine and plasma sodium 
(Na) concentrations were measured by phlamephotomer 
assay. The Cr clearance (CrCl), urine Na excretion (UNaV) 
and urine flow (UF) also were determined. After sacrificing, 
the left kidney and uterus were removed carefully and 
the kidney weight (KW) and uterus weight (UW) were 
determined using digital scale. The KW and UW were 
normalized based on 100 g of body weight. 
Statistical Analyses
The data were reported as mean±standard error of mean 
(SE). The ANOVA for repeated measures was applied to 
analyses the body weight change between the groups. One 
way ANOVA and Tukey as a post hoc test were employed to 
compare the kidney function markers between the groups. 
The p-value less than 0.05 was considered as significant.
The % change of BW in sham group was significantly 
different from estradiol treated groups (p<0.05). No 
significant differences between the groups were seen in the 
middle and lower panels indicated that estradiol treatment 
did not alter BW changes. 
The Effect of Estradiol on UUO
The UUO alone increased the serum levels of BUN and Cr, 
and kidney weight (KW) significantly (p<0.05). The ovaries 
were removed by ovariectomy, however the estradiol 
increased the UW statistically (p<0.05) as expected, but 
it did not alter the serum level of BUN and Cr, and KW 
when compared with control group (Figure 2). No urine was 
collected in this situation. 
The Effect of Estradiol in RUUO Models
The 3 days of UUO followed by 24 hours of RUUO in rats 
treated with different estradiol dosages did not alter the levels 
of BUN, Cr, CrCl, UF, UNaV and KW when compared with 
control group (Figure 3, left panel).  In addition, the 3 days 
of UUO followed by 3 days of RUUO in rats treated with 
different estradiol dosages also did not alter the mentioned 
markers (Figure 3, right panel). However, the UW increased 
significantly in all estradiol treated groups as expected 
(p<0.05) (Figure 3). 
Discussion
The adverse effect of UUO even after RUUO is a serious 
problem in clinic, and special care is needed to least the 
adverse side effects during or after RUUO. Estrogen as an 
antioxidant and cardiovascular protectant agent in female 
always has been nominated. The current study was designed 
to evaluate the effect of estradiol on renal function markers 
in conditions of UUO and RUUO in rats. The estradiol was 
administered at the time of obstruction, after RUUO or both, 
and the kidney functions markers were evaluated. It seems 
that the protective role of estradiol in renal system was not 
certain. 
 Previously, it is reported that UUO is accompanied 
with increasing of serum BUN and Cr levels (10), reduction 
of GFR about 20-70%  (11,12), decreasing of tubular  injury 
and interstitial fibrosis (13), reduction of UNaV and urine 
osmolality (14), and increasing of fibronectin expression 
(15). In our study, the serum level of BUN and Cr were 
increased by UUO possibly by renal fibrosis or GFR 
reduction. We did not measure the CrCl in UUO alone 
groups due to lack of urine flow. It seems this disturbance 
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Figure 1. The percentage (%) change of 
body weight (Bw) in 14 experimental 
groups (n = 6 in each group). The upper 
panel shows the % change of BW in 
animals subjected to unilateral ureteral 
obstruction (UUO) treated with vehicle 
or estradiol compared with sham group. 
These animals were sacrificed 3 days post 
obstruction. The % change of BW in sham 
group was significantly different from 
estradiol treated groups (p<0.05). The 
middle panel indicates the % change of 
BW in animals subjected to UUO treated 
with vehicle or estradiol, but at 3 days post 
obstruction, the obstruction was removed, 
and these animals were sacrificed 24 
hours post unilateral ureteral obstruction 
removal (RUUO) The lower panel 
shows the % change of BW in animals 
subjected to UUO with and without 
estradiol treatment, but at 3 days post 
obstruction, the obstruction was removed 
accompanied with estradiol treatment and 
these animals were sacrificed 3 days post 
RUUO. Analyses of variance for repeated 
measure data indicated no significant 
difference between the groups in middle 
and lower diagrams. The star (*) indicates 
significant difference from groups 3 and 4 
(p<0.05). See the text for groups’ detail. 
Figure 2. The serum levels of blood urea 
nitrogen (BUN), creatinine (Cr), kidney 
weight (Kw)/100 g body weight (Bw) 
and ureter weight/100 g Bw (Uw) in 
sham group (group 1), control group 
(group 2) and estradiol treated groups 
which received 0.1 mg/kg (Es0.1) or 0.5 
mg/kg (Es0.5) of estradiol (group 3 and 
4) (n =  6 in each group). All the groups 
except sham groups were subjected to 
unilateral ureteral obstruction (UUO). 
The p values were obtained by one way 
ANOVA, and the symbols of (*) and (#) 
showed significant difference from sham 
and control groups respectively (p<0.05) 
using Tukey as post hoc test.
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Figure 3. The serum levels of blood urea nitrogen (BUN), creatinine (Cr),  kidney weight (Kw)/ 100 g body weight (Bw) and ureter 
weight/100 g Bw (Uw) in control groups (group 5 and 10) and estradiol treated groups which received 0.1 mg/kg (Es0.1) or 0.5 
mg/kg (Es0.5) of estradiol (groups 6-9 and groups 11-14) (n = 6 in each group). All the groups were subjected to unilateral ureteral 
obstruction (UUO) for three day, and the obstruction was removed (called unilateral ureteral obstruction removal, RUUO) for 24 hours or 
3 days. The p values were obtained by one way ANOVA, and the symbols of (*) or (†) show significant difference from control or adjacent 
group (p<0.05) using Tukey as post hoc test.
decreased GFR and accumulated Cr or BUN in the body. 
Renal fibrosis due to UUO also causes damage to the 
kidney's  main  cells,  which  results  decreasing  of  GFR 
and  tubular  reabsorption,  and  increasing  of  serum  Cr 
levels.(16) Renin angiotensin system (RAS) also is another 
system that is disturbed by UUO.(17,18) The RAS plays a 
great role in the adjustment of the hemodynamics in UUO 
model  (19),  and  it  has  also  been shown that after UUO, 
the local  production  of angiotensin  II  increased  (20) 
which may result low renal blood flow (RBF) and GFR.
 Estradiol is usually thought to be renoprotective. It 
is anti-apoptosis (21) and anti-inflammation (22,23). In 
our model, the estradiol did not demonstrate an effective 
role on kidney functions markers. One possibility is related 
to estradiol treatment duration, because it is reported that 
estradiol had no effect on the serum levels of BUN and Cr, 
and CrCl in UO  model on day 2 and 6, but on day 16 the 
protective  effect  of  estradiol  on  renal  function  was 
detected.(8) However, in this study we used different doses 
of estradiol to determine the short time effect of estradiol, 
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Figure 4. The creatinine clearance (CrCl), urine flow (UF) and urine sodium excretion (UNaV) in control groups (group 5 and 10) 
and estradiol treated groups which received 0.1 mg/kg (Es0.1) or 0.5 mg/kg (Es0.5) of estradiol (groups 6-9 and groups 11-14) (n = 
6 in each group). All the groups were subjected to unilateral ureteral obstruction (UUO) for three day, and then obstruction was removed 
(called unilateral ureteral obstruction removal, RUUO) for 24 hours or 3 days. A one way ANOVA test shows no significant differences 
were detected between the groups.
because the estradiol effect may depend on treatment time 
and dosage. Our findings also did not demonstrate any 
considerable  protective  action of  estradiol  after  RUUO. The 
RUUO  eliminated  the  initial  stimulus, but  the  interstitial 
damage may be remained. Chevalier, et al., reported that 
initial urinary tract injury was remained 1 month after the 
surgery.(24) Other study indicated that improving of the 
tubular function in obstructive kidney needs to more than 2 
weeks after the RUUO.(25) Hasanshahi and Nematbakhsh 
reported that 3-days UUO decreased RBF and increased 
renal vascular resistances (RVR)  in ipsilatral kidney.(26) It 
is  also  reported  the  significant  increase  of  GFR  at  72 
hours after RUUO, while  no change in UNaV shortly after 
RUUO was observed.(27) In a preliminary report founded 
that three months after 5-days of  UUO in the neonatal rat, 
the GFR of the post obstructed kidney was reduced by 50% 
(28). Some of these findings were similar to our study; 
however our data did not confirm the protective effect of 
estradiol after RUUO possibly due to non-chronic treatment 
of estradiol. 
Conclusion
Although estradiol is a well-known protective agent in 
cardiovascular system, however our findings suggest that 
the short time effect of different doses of estradiol on UUO 
or on RUUO models is not certain, and its protective effect 
may occur long time after RUUO while short-term injury 
induced by UUO progress even after RUUO. Acknowledgment
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